Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody. (Q54040210)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Micah A Luftig

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Marco Mattu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Paolo Di Giovine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Romas Geleziunas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Renee Hrin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Elisabetta Bianchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Michael D Miller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Antonello Pessi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Andrea Carfí

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

23 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

Nature Structural & Molecular Biology

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

740-747

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862157%20AND%20SRC:MED&resulttype=core&format=json

HIV vaccine design and the neutralizing antibody problem

27 December 2019

cites work

1 reference

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

21 January 2018

1 reference

Antibody neutralization and escape by HIV-1

21 January 2018

1 reference

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

21 January 2018

1 reference

gp120: Biologic aspects of structural features

21 January 2018

1 reference

Antibody vs. HIV in a clash of evolutionary titans

21 January 2018

1 reference

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

21 January 2018

1 reference

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

21 January 2018

1 reference

Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1

21 January 2018

1 reference

Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody

21 January 2018

1 reference

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

21 January 2018

1 reference

The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5.

21 January 2018

1 reference

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

21 January 2018

1 reference

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

21 January 2018

1 reference

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

21 January 2018

1 reference

Atomic structure of a thermostable subdomain of HIV-1 gp41

21 January 2018

1 reference

Atomic structure of the ectodomain from HIV-1 gp41

21 January 2018

1 reference

Core structure of gp41 from the HIV envelope glycoprotein

21 January 2018

1 reference

Capture of an early fusion-active conformation of HIV-1 gp41

21 January 2018

1 reference

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition

21 January 2018

1 reference

Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements

21 January 2018

1 reference

Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket

21 January 2018

1 reference

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

21 January 2018

1 reference

Covalent trimers of the internal N-terminal trimeric coiled-coil of gp41 and antibodies directed against them are potent inhibitors of HIV envelope-mediated cell fusion.

21 January 2018

1 reference

A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope

21 January 2018

1 reference

Protein design of an HIV-1 entry inhibitor

21 January 2018

1 reference

Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region

21 January 2018

1 reference

Standard conformations for the canonical structures of immunoglobulins

21 January 2018

1 reference

Molecular recognition in antibody-antigen complexes

21 January 2018

1 reference

Shape complementarity at protein/protein interfaces

21 January 2018

1 reference

Interactions of protein antigens with antibodies

21 January 2018

1 reference

The structure of an HIV-1 specific cell entry inhibitor in complex with the HIV-1 gp41 trimeric core

21 January 2018

1 reference

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120

21 January 2018

1 reference

Stoichiometry of antibody neutralization of human immunodeficiency virus type 1.

21 January 2018

1 reference

Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody

21 January 2018

1 reference

Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41

21 January 2018

1 reference

Rational design of faster associating and tighter binding protein complexes.

21 January 2018

1 reference

Antibody-antigen interactions: contact analysis and binding site topography.

21 January 2018

1 reference

Antibody pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins

21 January 2018

1 reference

Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection

21 January 2018

1 reference

The CCP4 suite: programs for protein crystallography

21 January 2018

1 reference

Automated protein model building combined with iterative structure refinement

21 January 2018

1 reference

21 January 2018

gp41: HIV's shy protein

1 reference

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

21 January 2018

1 reference

Steric accessibility of the HIV-1 gp41 N-trimer region

21 January 2018

1 reference

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

31 March 2020

1 reference